Dana N - Search Results

1

The dual role of Nrf2 in melanoma: a systematic review.

Malakoutikhah Z, Mohajeri Z, Dana N, Haghjooy Javanmard S. Malakoutikhah Z, et al. Among authors: dana n. BMC Mol Cell Biol. 2023 Feb 6;24(1):5. doi: 10.1186/s12860-023-00466-5. BMC Mol Cell Biol. 2023. PMID: 36747120 Free PMC article.

2

Effect of serum magnesium levels on outcomes of patients hospitalized with COVID-19.

Dana N, Vaseghi G, Nasirian M, Laher I, MantEghinejad A, Mosayebi A, Javanmard SH. Dana N, et al. Bratisl Lek Listy. 2023;124(6):466-470. doi: 10.4149/BLL_2023_071. Bratisl Lek Listy. 2023. PMID: 36876382

3

Prognostic value of the high-mobility group box-1 in young patients with chest pain.

Haghjooy-Javanmard S, Sadeghi M, Safavi S, Gheraati M, Dana N. Haghjooy-Javanmard S, et al. Among authors: dana n. ARYA Atheroscler. 2014 May;10(3):154-8. ARYA Atheroscler. 2014. PMID: 25161686 Free PMC article.

4

Optimisation of processing variables effective on self-assembly of folate targeted Synpronic-based micelles for docetaxel delivery in melanoma cells.

Taymouri S, Varshosaz J, Hassanzadeh F, Haghjooy Javanmard S, Dana N. Taymouri S, et al. Among authors: dana n. IET Nanobiotechnol. 2015 Oct;9(5):306-13. doi: 10.1049/iet-nbt.2014.0076. IET Nanobiotechnol. 2015. PMID: 26435285

5

Cytotoxic Evaluation of Some Fused Pyridazino- and Pyrrolo-quinazolinones Derivatives on Melanoma and Prostate Cell Lines.

Vaseghi G, Jafari E, Hassanzadeh F, Haghjooy-Javanmard S, Dana N, Rafieian-Kopaei M. Vaseghi G, et al. Among authors: dana n. Adv Biomed Res. 2017 Jun 27;6:76. doi: 10.4103/2277-9175.209049. eCollection 2017. Adv Biomed Res. 2017. PMID: 28706884 Free PMC article.

6

Influence of morphine on TLR4/ NF-kB signaling pathway of MCF-7 cells.

Haghjooy-Javanmard S, Ghasemi A, Laher I, Zarrin B, Dana N, Vaseghi G. Haghjooy-Javanmard S, et al. Among authors: dana n. Bratisl Lek Listy. 2018;119(4):229-233. doi: 10.4149/BLL_2018_043. Bratisl Lek Listy. 2018. PMID: 30113863

7

Crosstalk between Peroxisome Proliferator-Activated Receptors and Toll-Like Receptors: A Systematic Review.

Dana N, Vaseghi G, Haghjooy Javanmard S. Dana N, et al. Adv Pharm Bull. 2019 Feb;9(1):12-21. doi: 10.15171/apb.2019.003. Epub 2019 Feb 21. Adv Pharm Bull. 2019. PMID: 31011554 Free PMC article. Review.

8

The effect of fenofibrate, a PPARα activator on toll-like receptor-4 signal transduction in melanoma both in vitro and in vivo.

Dana N, Haghjooy Javanmard S, Vaseghi G. Dana N, et al. Clin Transl Oncol. 2020 Apr;22(4):486-494. doi: 10.1007/s12094-019-02150-7. Epub 2019 Jun 7. Clin Transl Oncol. 2020. PMID: 31175545

9

PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling.

Dana N, Vaseghi G, Haghjooy Javanmard S. Dana N, et al. J Pharm Pharm Sci. 2019;22(1):418-423. doi: 10.18433/jpps30626. J Pharm Pharm Sci. 2019. PMID: 31509504 Free article.

10

Activation of PPARγ Inhibits TLR4 Signal Transduction Pathway in Melanoma Cancer In Vitro.

Dana N, Vaseghi G, Haghjooy Javanmard S. Dana N, et al. Adv Pharm Bull. 2020 Jul;10(3):458-463. doi: 10.34172/apb.2020.056. Epub 2020 May 11. Adv Pharm Bull. 2020. PMID: 32665906 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters